Glenn Dubin's most recent trade in C4 Therapeutics Inc was a trade of 1,358 Common Stock done at an average price of $8.1 . Disclosure was reported to the exchange on April 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 01 Apr 2024 | 1,358 | 22,075 | - | 8.1 | 11,000 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 6.52 per share. | 02 Jan 2024 | 1,687 | 20,717 | - | 6.5 | 10,999 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 2.83 per share. | 03 Jul 2023 | 3,887 | 12,560 | - | 2.8 | 11,000 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 3.20 per share. | 03 Apr 2023 | 3,438 | 8,673 | - | 3.2 | 11,002 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 6.38 per share. | 03 Jan 2023 | 1,725 | 5,235 | - | 6.4 | 11,006 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 8.69 per share. | 03 Oct 2022 | 1,265 | 3,510 | - | 8.7 | 10,993 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 8.03 per share. | 01 Jul 2022 | 1,372 | 2,245 | - | 8.0 | 11,017 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 26.46 per share. | 04 Apr 2022 | 379 | 873 | - | 26.5 | 10,028 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 31.58 per share. | 04 Jan 2022 | 199 | 494 | - | 31.6 | 6,284 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 44.99 per share. | 04 Oct 2021 | 138 | 295 | - | 45.0 | 6,209 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 39.72 per share. | 02 Jul 2021 | 157 | 157 | - | 39.7 | 6,236 | Common Stock |
| C4 Therapeutics Inc | Glenn Dubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 41,200 | 41,200 | - | - | Stock Option (Right to Buy) |